Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...
At eight years old, I had my third open-heart surgery — this time, to “tune up” my Fontan and implant my first pacemaker.
Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA ...
Good morning. Welcome to today's conference call to discuss Kimberly-Clark's acquisition of Kenvue. [Operator Instructions]. With that, I would now like to turn the call over to Chris Jakubik, ...
Cost of service revenue was $0.9 million for the three months ended September 30 ... maintain or improve functional class, delay disease progression and improve quality of life. About Pulmonary ...
Royalty revenue increased to $1.5 million in the third quarter of 2025 compared to $0.9 million ... a tissue-based comprehensive genomic profiling test to identify and enroll patients whose tumors are ...
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...
Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at ...
With the acquisition, Kimberly-Clark gains popular brands, including Neutrogena, Aveeno, Listerine, Benadryl, Band-Aid, and ...
13hon MSN
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Shareholders of Kimberly-Clark<a class="excerpt-read- ...
Plant a seed and, if the conditions are right, the seed grows. The process seems simple enough at first glance and is something many of us may feel like we learned in elementary school.
Precision Medicine Group (Precision), a leading provider of next-generation drug development, CRO and commercialization services, today announced the launch of Institute@Precision, an expert community ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results